Responses
Clinical/translational cancer immunotherapy
Original research
Virological breakthrough after immune checkpoint inhibitor and nucleos(t)ide analog treatment in patients with hepatitis B surface antigen positive hepatocellular carcinoma: a real-world study
Compose a Response to This Article
Other responses
No responses have been published for this article.
